| Fragmented sleep accelerates tumor growth and progression through recruitment of tumor-associated macrophages and TLR4 signaling F Hakim, Y Wang, SXL Zhang, J Zheng, ES Yolcu, A Carreras, A Khalyfa, ... Cancer research 74 (5), 1329-1337, 2014 | 201 | 2014 |
| Ex vivo expansion of CD4+ CD25+ FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling KG Elpek, ES Yolcu, DDH Franke, C Lacelle, RH Schabowsky, H Shirwan The Journal of Immunology 179 (11), 7295-7304, 2007 | 178 | 2007 |
| CHRONIC ALLOGRAFT REJECTION: Do the Th2 Cells Preferentially Induced by Indirect Alloantigen Recognition Play a Dominant Role?: 1 H Shirwan Transplantation 68 (6), 715-726, 1999 | 177 | 1999 |
| Local immunomodulation with Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance DM Headen, KB Woodward, MM Coronel, P Shrestha, JD Weaver, ... Nature materials 17 (8), 732-739, 2018 | 169 | 2018 |
| Vasculogenic hydrogel enhances islet survival, engraftment, and function in leading extrahepatic sites JD Weaver, DM Headen, J Aquart, CT Johnson, LD Shea, H Shirwan, ... Science advances 3 (6), e1700184, 2017 | 166 | 2017 |
| Induction of tolerance using Fas ligand: a double-edged immunomodulator N Askenasy, ES Yolcu, I Yaniv, H Shirwan Blood 105 (4), 1396-1404, 2005 | 163 | 2005 |
| Current challenges for cancer vaccine adjuvant development WS Bowen, AK Svrivastava, L Batra, H Barsoumian, H Shirwan Expert review of vaccines 17 (3), 207-215, 2018 | 154 | 2018 |
| CD4+ CD25+ T regulatory cells dominate multiple immune evasion mechanisms in early but not late phases of tumor development in a B cell lymphoma model KG Elpek, C Lacelle, NP Singh, ES Yolcu, H Shirwan The Journal of Immunology 178 (11), 6840-6848, 2007 | 151 | 2007 |
| Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection ES Yolcu, N Askenasy, NP Singh, SEL Cherradi, H Shirwan Immunity 17 (6), 795-808, 2002 | 124 | 2002 |
| Vaccination with an adenoviral vector expressing calreticulin-human papillomavirus 16 E7 fusion protein eradicates E7 expressing established tumors in mice JG Gomez-Gutierrez, KG Elpek, R Montes de Oca-Luna, H Shirwan, ... Cancer Immunology, Immunotherapy 56, 997-1007, 2007 | 110 | 2007 |
| Costimulation as a platform for the development of vaccines: a peptide-based vaccine containing a novel form of 4-1BB ligand eradicates established tumors RK Sharma, KG Elpek, ES Yolcu, RH Schabowsky, H Zhao, ... Cancer research 69 (10), 4319-4326, 2009 | 103 | 2009 |
| Protease-degradable microgels for protein delivery for vascularization GA Foster, DM Headen, C González-García, M Salmerón-Sánchez, ... Biomaterials 113, 170-175, 2017 | 100 | 2017 |
| Rapid on-demand extracellular vesicle augmentation with versatile oligonucleotide tethers SS Yerneni, S Lathwal, P Shrestha, H Shirwan, K Matyjaszewski, L Weiss, ... ACS nano 13 (9), 10555-10565, 2019 | 93 | 2019 |
| Longitudinal tracking of recipient macrophages in a rat chronic cardiac allograft rejection model with noninvasive magnetic resonance imaging using micrometer-sized … Q Ye, YL Wu, LM Foley, TK Hitchens, DF Eytan, H Shirwan, C Ho Circulation 118 (2), 149-156, 2008 | 89 | 2008 |
| Targeting CD4+ CD25+ FoxP3+ regulatory T-cells for the augmentation of cancer immunotherapy. RH Schabowsky, S Madireddi, R Sharma, ES Yolcu, H Shirwan Current Opinion in Investigational Drugs (London, England: 2000) 8 (12 …, 2007 | 81 | 2007 |
| Pancreatic islets engineered with SA-FasL protein establish robust localized tolerance by inducing regulatory T cells in mice ES Yolcu, H Zhao, L Bandura-Morgan, C Lacelle, KB Woodward, ... The Journal of Immunology 187 (11), 5901-5909, 2011 | 80 | 2011 |
| Xenoantibody response of patients with severe acute liver failure exposed to porcine antigens following treatment with a bioartificial liver A Baquerizo, A Mhoyan, H Shirwan, J Swensson, RW Busuttil, ... Transplantation proceedings 29 (1), 964-965, 1997 | 74 | 1997 |
| A novel approach to cancer immunotherapy: tumor cells decorated with CD80 generate effective antitumor immunity NP Singh, ES Yolcu, DD Taylor, C Gercel-Taylor, DS Metzinger, ... Cancer research 63 (14), 4067-4073, 2003 | 73 | 2003 |
| Peptides derived from α-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac … H SHIRwAN, M LEAMER, HK WANG, L MAKOWKA, DV CRAMER Transplantation 59 (3), 401-409, 1995 | 69 | 1995 |
| Immunotherapy via PD-L1–presenting biomaterials leads to long-term islet graft survival MM Coronel, KE Martin, MD Hunckler, G Barber, EB O’Neill, JD Medina, ... Science Advances 6 (35), eaba5573, 2020 | 67 | 2020 |
